Pylvänäinen Kirsi, Kairaluoma Matti, Mecklin Jukka-Pekka
Department of Surgery, Jyväskylä Central Hospital, Keskussairaalantie 19, FIN-40620, Jyväskylä, Finland.
Fam Cancer. 2006;5(2):175-8. doi: 10.1007/s10689-005-5442-3.
Nation-wide preventative colonoscopic surveillance for mutation carriers in HNPCC families has been organized since the early 1980 by the Finnish HNPCC registry. After characterization of MMR genes, a predisposing mutation has been verified in 111 HNPCC families and over 1500 family members at risk have been tested. The aim of this study was to evaluate the compliance and satisfaction of mutation carriers during life-long colonoscopic surveillance.
Hospital records of long-term surveillance were obtained for all mutation carriers (n=664). A questionnaire assessing overall experience, willingness to continue the surveillance, painfulness (a three-rank scale), possible interruption of endoscopy and the need for pain relief medication during colonoscopy, was sent to all living mutation carriers (n=587). The questionnaire was returned by 441 persons (75%) of whom 415 persons under colonoscopic surveillance were included in the study and 26 young mutation carriers excluded as they were still pending their first endoscopy.
Out of 664 mutation carriers, surveillance had been interrupted in 8 cases (1.2%). Colonoscopies were described as painful by 151 (36%), uncomfortable by 161 (39%) and easy by 103 (25%) patients. Endoscopy was more often rated as painful by females (1.36, SD 0.71) than by males (0.86, SD 0.75), P<0.001. Medication for pain during colonoscopies was administered more often to females (32%) than males (15%), P<0.001. Colonoscopy had to be discontinued because of pain at least once in 10% of the patients.
Patient compliance under life-long surveillance was excellent, but painfulness, especially in females, must be seen as a risk for compliance and the quality of endoscopies.
自20世纪80年代初以来,芬兰遗传性非息肉病性结直肠癌(HNPCC)登记处组织了针对HNPCC家族中突变携带者的全国性预防性结肠镜监测。在对错配修复(MMR)基因进行特征分析后,已在111个HNPCC家族中验证了一个易感突变,并对1500多名有风险的家庭成员进行了检测。本研究的目的是评估突变携带者在终身结肠镜监测期间的依从性和满意度。
获取了所有突变携带者(n = 664)的长期监测医院记录。向所有在世的突变携带者(n = 587)发送了一份问卷,评估总体体验、继续监测的意愿、疼痛程度(三级量表)、结肠镜检查可能中断的情况以及结肠镜检查期间使用止痛药物的必要性。441人(75%)回复了问卷,其中415名接受结肠镜监测的患者被纳入研究,26名年轻突变携带者被排除,因为他们仍在等待首次结肠镜检查。
在664名突变携带者中,有8例(1.2%)监测被中断。151名患者(36%)将结肠镜检查描述为疼痛,161名患者(39%)描述为不舒服,103名患者(25%)描述为轻松。女性(1.36,标准差0.71)比男性(0.86,标准差0.75)更常将结肠镜检查评为疼痛,P<0.001。结肠镜检查期间,女性(32%)比男性(15%)更常使用止痛药物,P<0.001。至少有10%的患者因疼痛而不得不中断结肠镜检查。
终身监测下患者的依从性极佳,但疼痛,尤其是女性的疼痛,必须被视为依从性和结肠镜检查质量的一个风险因素。